MARKET

LGND

LGND

Ligand Pharma
NASDAQ
198.56
+3.97
+2.04%
Opening 13:04 12/18 EST
OPEN
195.03
PREV CLOSE
194.59
HIGH
198.96
LOW
194.00
VOLUME
176.12K
TURNOVER
--
52 WEEK HIGH
212.49
52 WEEK LOW
93.58
MARKET CAP
3.91B
P/E (TTM)
95.55
1D
5D
1M
3M
1Y
5Y
1D
CFO Makes Significant Move with Ligand Pharma Stock Sale
TipRanks · 1d ago
Ligand Pharmaceuticals CFO Octavio Espinoza Reports Sale of Common Shares
Reuters · 1d ago
Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), MiMedx Group (MDXG)
TipRanks · 2d ago
Promising Developments and Revenue Prospects Reinforce Buy Rating for Ligand Pharma
TipRanks · 3d ago
Weekly Report: what happened at LGND last week (1208-1212)?
Weekly Report · 3d ago
Here's How Much $100 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth Today
Benzinga · 12/10 21:30
Ligand Pharmaceuticals Price Target Raised to $235.00/Share From $234.00 by RBC Capital
Dow Jones · 12/10 14:36
Ligand Pharmaceuticals Is Maintained at Outperform by RBC Capital
Dow Jones · 12/10 14:36
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.